Acclaim Dermatology PLLC

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Atopic dermatitis (eczema)

Closed trials

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source